HKSE:02595 (China)
Â
Ordinary Shares-Class H
HK$
25.48
-0.48 (-1.85%)
Sep 11
Business Description
GenFleet Therapeutics (Shanghai) Inc
ISIN : CNE1000074L2
Share Class Description:
HKSE:02595: Ordinary Shares-Class HTotal Employee Number:
102Compare
Compare
Traded in other countries / regions
02595.Hong KongY3L.Germany Index Membership
Hong Kong Stock Connect IPO Date
2025-09-19Description
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 12.9 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.31 | |||||
Beneish M-Score | -6.39 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5.71 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 47.38 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.13 | |||||
9-Day RSI | 26.06 | |||||
14-Day RSI | 33.6 | |||||
3-1 Month Momentum % | 0.99 | |||||
6-1 Month Momentum % | -8.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.85 | |||||
Quick Ratio | 5.85 | |||||
Cash Ratio | 5.49 | |||||
Days Inventory | 46.64 | |||||
Days Sales Outstanding | 179.7 | |||||
Days Payable | 152.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.45 | |||||
Operating Margin % | -460.77 | |||||
Net Margin % | -1542.48 | |||||
EBITDA Margin % | -1524.54 | |||||
FCF Margin % | -157.31 | |||||
OCF Margin % | -157.18 | |||||
ROE % | -450.86 | |||||
ROA % | -83.37 | |||||
ROIC % | -33.22 | |||||
ROC (Joel Greenblatt) % | -6067.89 | |||||
ROCE % | -408.26 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 99.14 | |||||
PB Ratio | 5.27 | |||||
Price-to-Tangible-Book | 5.28 | |||||
EV-to-EBIT | -5.38 | |||||
EV-to-EBITDA | -5.42 | |||||
EV-to-Revenue | 82.6 | |||||
EV-to-FCF | -52.51 | |||||
| Price-to-Net-Current-Asset-Value | 5.39 | |||||
| Price-to-Net-Cash | 5.8 | |||||
Earnings Yield (Greenblatt) % | -18.59 | |||||
FCF Yield % | -1.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GenFleet Therapeutics (Shanghai) Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 95.001 | ||
| EPS (TTM) (HK$) | -3.951 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 33.6 | ||
| 14-Day ATR (HK$) | 2.067087 | ||
| 20-Day SMA (HK$) | 29.844 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 19.6 - 52.9 | ||
| Shares Outstanding (Mil) | 383.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GenFleet Therapeutics (Shanghai) Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GenFleet Therapeutics (Shanghai) Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
GenFleet Therapeutics (Shanghai) Inc Frequently Asked Questions
What is GenFleet Therapeutics (Shanghai) Inc(HKSE:02595)'s stock price today?
The current price of HKSE:02595 is HK$25.48. The 52 week high of HKSE:02595 is HK$52.90 and 52 week low is HK$19.60.
When is next earnings date of GenFleet Therapeutics (Shanghai) Inc(HKSE:02595)?
The next earnings date of GenFleet Therapeutics (Shanghai) Inc(HKSE:02595) is .
Does GenFleet Therapeutics (Shanghai) Inc(HKSE:02595) pay dividends? If so, how much?
GenFleet Therapeutics (Shanghai) Inc(HKSE:02595) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers